Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis
(Q35900978)
scientific article published on 28 March 2007
scientific article published on 28 March 2007
Language: